Freelance Subject Matter Experts - Pharmaceutical Sciences and Medicinal Chemistry
Cactus Communications is seeking a Freelance Subject Matter Expert in pharmaceutical sciences and medicinal chemistry to join their education team. The role involves reviewing and evaluating AI-generated content against medical curriculum standards for quality and accuracy. Candidates must hold a PhD and have experience with research databases like Reaxys or Embase. This position operates on a project basis to support medical student learning resources.
50k new jobs listed every day. Install TAL to find more jobs like this.
Experience
2+ years
Function
Education
Work mode
Onsite, India
Company
Tier 2
What you will work on
Cactus Communications is seeking a Freelance Subject Matter Expert in pharmaceutical sciences and medicinal chemistry to join their education team. The role involves reviewing and evaluating AI-generated content against medical curriculum standards for quality and accuracy. Candidates must hold a PhD and have experience with research databases like Reaxys or Embase. This position operates on a project basis to support medical student learning resources.
TAL's take
Stable domain and company, but a freelance role with specific academic requirements.
Very clear responsibilities regarding academic evaluation and specific scientific expertise required.
Must haves
- PhD in Chemistry or Biomedical Sciences
- Minimum 2 years of relevant experience
- Experience using Reaxys or Embase database
- Ability to evaluate AI-generated scientific content
Tools and skills
About the company
Established global academic and scientific communication services company.
Posts mentioning Cactus Communications
Stop making babies, please!
Earth doesn’t need another generation of mental health advocates who don't want to work. Want to contribute to the planet? Adopt a cactus instead.
Lohum Plans $200M Fundraise Ahead of 2027 IPO
- Lohum, a critical mineral refining and processing company, is planning to raise $200 million from private equity funds as it prepares for an IPO in early 2027. - The company aims to expand its capacity in lithium, nickel, platinum, palladium, and cathode active materials across multiple locations in India. - Lohum has already raised $100 million since its inception in 2018, with investors including Singularity Growth, Baring Private Equity, and Cactus Venture Partners. - The company announced the expansion of its lithium refining capabilities with a new 1,000-tonnes-per-annum facility, making it one of the largest lithium refiners outside of China. - Lohum's current annual revenue stands at around ₹1,000 crore, with plans to quadruple it by 2027 through significant capacity expansions and new projects. Source: [The Economic Times](https://economictimes.indiatimes.com/markets/ipos/fpos/lohum-plans-to-raise-200-million-ahead-of-ipo/articleshow/118771793.cms), [Mint](https://www.livemint.com/companies/lohum-ipo-in-early-2027-mineral-refining-lithium-cobalt-refiners-11741268695124.html)